SCHEMBL6946551

SCHEMBL6946551

NS(=O)(=O)c1ccc(Nc2c([N+](=O)[O-])cc(C(=O)O)c(Nc3ccc(I)cc3Cl)c2F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 3/20 0.52
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 4/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAP2K2 P36507 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CA1 P00915 6/20 0.39
CA2 P00918 6/20 0.39
AURKA O14965 2/20 0.39
TNFRSF1A P19438 2/20 0.39
MAP3K9 P80192 2/20 0.39
ABL1 P00519 1/20 0.39
LCK P06239 1/20 0.39
SRC P12931 1/20 0.39
CLK1 P49759 1/20 0.39
KDR P35968 1/20 0.39
RAF1 P04049 1/20 0.39
PDGFRB P09619 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947427 0.91 MAP2K1 (0.48) MAP2K1MEN1KMT2AMAPTPOLB
SCHEMBL6951223 0.91 MAP2K1 (0.43) MAP2K1MEN1KMT2AMAPTPOLB
SCHEMBL6944361 0.89 MAP2K1 (0.57) MAP2K1MEN1KMT2AMAPTMAP2K2
SCHEMBL6035272 0.89 MAP2K1 (0.64) MAP2K1MEN1KMT2AMAP2K2AURKA
SCHEMBL6946808 0.87 MAP2K1 (0.51) MAP2K1MEN1KMT2AMAPTPOLB
SCHEMBL6944152 0.84 MAP2K1 (0.61) MAP2K1MEN1KMT2ATDP1MAP2K2
SCHEMBL6949973 0.84 MAP2K1 (0.50) MAP2K1MEN1KMT2AMAPTTDP1
SCHEMBL6948285 0.83 ALDH1A1 (0.42) MAP2K1MEN1KMT2AMAPTPOLB
SCHEMBL6946582 0.82 MAP2K1 (0.48) MAP2K1MEN1KMT2AMAPTTDP1
SCHEMBL6035416 0.82 MAP2K1 (0.60) MAP2K1MEN1KMT2AMAP2K2AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP claimed
JP-2003504401-A 2003-02-04 JP claimed
US-6506798-B1 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors WARNER-LAMBERT COMPANY 2003-01-14 US claimed
CN-1365277-A Methods of treating chronic pain using MEK inhibitors VARNER LAMBERT CO (US) 2002-08-21 CN claimed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP claimed
EP-1144362-A1 4-ARYLAMINO, 4-ARYLOXY, AND 4-ARYLTHIO DIARYLAMINES AND DERIVATIVES THEREOF AS SELECTIVE MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-10-17 EP claimed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO claimed
WO-2000041994-A1 4-ARYLAMINO, 4-ARYLOXY, AND 4-ARYLTHIO DIARYLAMINES AND DERIVATIVES THEREOF AS SELECTIVE MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-07-20 WO claimed
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP disclosed
US-6506798-B1 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors WARNER-LAMBERT COMPANY 2003-01-14 US disclosed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP disclosed
EP-1144362-A1 4-ARYLAMINO, 4-ARYLOXY, AND 4-ARYLTHIO DIARYLAMINES AND DERIVATIVES THEREOF AS SELECTIVE MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-10-17 EP disclosed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO disclosed
WO-2000041994-A1 4-ARYLAMINO, 4-ARYLOXY, AND 4-ARYLTHIO DIARYLAMINES AND DERIVATIVES THEREOF AS SELECTIVE MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-07-20 WO disclosed